Hispanic Accrual on Randomized Cancer Clinical Trials: A Call to Arms

Yazar: Parra, Alberto, Karnad, Anand B., Thompson, Ian M.
Baskı/Yayın Bilgisi 2014

ReCAP: Association Between the Number of Suppliers for Critical Antineoplastics and Drug Shortages: Implications for Future Drug Shortages and Treatment

Yazar: Parsons, Helen M., Schmidt, Susanne, Karnad, Anand B., Liang, Yuanyuan, Pugh, Mary Jo, Fox, Erin R.
Yayımlandı J Oncol Pract (2016)

Should we move beyond VEGF inhibition in metastatic colorectal cancer? Lessons from early phase clinical trials

Yazar: Patel, Sukeshi R., Karnad, Anand B., Ketchum, Norma S., Pollock, Brad H., Sarantopoulos, John, Weitman, Steven, Mahalingam, Devalingam
Baskı/Yayın Bilgisi 2014

Use of Milestones and Development of Entrustable Professional Activities in 2 Hematology/Oncology Training Programs

Yazar: Shumway, Nathan M., Dacus, Jennifer J., Lathrop, Kate I., Hernandez, Elizabeth P., Miller, Maria, Karnad, Anand B.
Yayımlandı J Grad Med Educ (2015)

Safety and pharmacodynamics of the PDE4 inhibitor roflumilast in advanced B cell malignancies

Yazar: Kelly, Kevin, Mejia, Alex, Suhasini, Avvaru, Lin, An-Ping, Kuhn, John, Karnad, Anand B., Weitman, Steven, Aguiar, Ricardo C. T.
Yayımlandı Clin Cancer Res (2016)

Breast Cancer Treatment Delays in a Majority Minority Community: Is There a Difference?

Yazar: Parsons, Helen M., Lathrop, Kate I., Schmidt, Susanne, Mazo-Canola, Marcela, Trevino-Jones, Jessica, Speck, Heather, Karnad, Anand B.
Yayımlandı J Oncol Pract (2015)